Clinical Trial Update: Testing the Combination of Pevonedistat With Chemotherapy for Bile Duct Cancer of the Liver [Phase 2]

View source ↗

Summary

Phase 2 clinical trial results update evaluating pevonedistat in combination with chemotherapy for biliary tract cancers (cholangiocarcinoma) and hepatocellular…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cholangiocarcinoma
• Hepatocellular Carcinoma

Drugs mentioned

• Pevonedistat (pevonedistat)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Metastatic Cholangiocarcinoma, Metastatic Hepatocellular Carcinoma | Phase 2 | Status: ACTIVE_NOT_RECRUITING | Results posted: 2025-01-07